Zhejiang Jolly Pharmaceutical Co., LTD
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Zuoli Pharmaceutical Co., Ltd. (hereinafter referred to as "the company") was established in January 2000, located at the foot of the picturesque Mogan Mountains, covering an area of over 260 acres and a construction area of over 150000 square meters. It is a national high-tech modern pharmaceutical enterprise that integrates scientific research, production, and sales. On February 22, 2011, the company successfully landed on the ChiNext (stock code 300181). At present, the company has five wholly-owned subsidiaries, namely Zhejiang Zuoli Health Industry Investment Management Co., Ltd., Zhejiang Zuoli Health Technology Co., Ltd., Zhejiang Zuoli Baicao Pharmaceutical Co., Ltd., Zhejiang Zuoli Baicao Traditional Chinese Medicine Tablets Co., Ltd., and Deqing Zuoli Pharmaceutical Technology Co., Ltd., as well as a controlling subsidiary of Qinghai Everest Cordyceps Sinensis Pharmaceutical Co., Ltd., in which it participates in Technology Biopharmaceutical Co., Ltd. The company has a modern production line for raw materials, extraction, tablets, capsules, decoction pieces, granules, and freeze-dried powder needles. The company is based on the biological fermentation technology of medicinal fungi to produce traditional Chinese medicine products. Through years of research and development and improvement, it has achieved the industrial production of rare traditional Chinese medicine - Wulingshen, and achieved the combination of traditional Chinese medicine and modern biotechnology. Wulingshen is a medicinal fungus that grows in abandoned termite nests deep underground, with high nourishing functions and medicinal value, and is extremely rare. Due to the unique growth environment, harvesting is very difficult and difficult to cultivate artificially. The company has achieved industrial and large-scale production of Wuling ginseng fermentation bacterial powder (Wuling mushroom powder) by utilizing strains isolated from natural Wuling ginseng and modern biological fermentation technology. Wuling mushroom powder and Wuling capsules are a new class of traditional Chinese medicine in China. Wuling Capsules are listed in the national medical insurance catalog and protected by traditional Chinese medicine. They have the effect of "tonifying the kidney, strengthening the brain, nourishing the heart and calming the mind", and are mainly used in clinical practice for depression, anxiety, and insomnia. In May 2019, Wuling Capsule was selected as one of the first batch of "Zhejiang Famous Medicines". Wuling Capsules, Bailing Tablets, and Lingze Tablets have all entered the national medical insurance catalog and national basic drug catalog. In addition, Zuoli Baicao's "Diqing Brand" traditional Chinese medicine slices have been awarded the Zhejiang Province Famous Brand Product and have achieved traceability from the field to the bowl. Koji Biotechnology, a joint venture of the company, is committed to developing innovative tumor immunotherapy drugs such as CAR-T cells. For many years, the company has adhered to product innovation, market innovation, and management innovation, actively exploring the market, continuously achieving significant growth in sales, profits, and taxes, and achieving rapid development. At the same time, it has also won the titles of "High tech Enterprise", "National Green Factory", "National Civilized Unit", "National Model Enterprise for Harmonious Labor Relations", "National May Day Labor Award", "Zhejiang Green Enterprise", "Zhejiang Honesty and Law-abiding Enterprise", "Zhejiang Technology Innovation Demonstration Enterprise", "Zhejiang Patent Demonstration Enterprise", "Zhejiang Excellent Private Enterprise", and "Zhejiang Famous Firm" Honors such as "Zhejiang Province AAA level contract abiding and trustworthy enterprise", "Zhejiang Province Credit Management Demonstration Enterprise", "Zhejiang Province Science and Technology Progress Award", and "Provincial Disabled Care Enterprise". The company will always adhere to the mission of "assisting human health and committed to the development of traditional Chinese medicine", advocate the core concept of "innovation, dedication, excellence, cooperation, and win-win", adhere to the starting point of the Wuling series of products, and take the industrialization of medicinal fungi as its own responsibility, to create a leading goose in the field of large-scale pharmaceutical fungi in China. |
| Headquarter | Huzhou |
| Establish Date | 1/28/2000 |
| Listed Code | 300181.SZ |
| Listed Date | 2/22/2011 |
| Chairman | Yu Youqiang. |
| CEO | Wang Tao. |
| Website | www.zuoli.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
